A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer GrowthNilotpal Roy, Matthew P. Patricelli, Tine Wyseure et al.|Cancer Discovery|2025Cited by 14
Abstract CT241: Phase 2 window of opportunity trial of pyrimethamine in locoregionally advanced head and neck squamous cell carcinomaPaul Zolkind, Michael B. Major, Emily Wilkerson et al.|Cancer Research|2026Cited by 0
Supplementary Figure 7 from A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer GrowthNilotpal Roy, Matthew P. Patricelli, Tine Wyseure et al.|Unknown|2026Cited by 0
Supplementary Figure 10 from A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer GrowthNilotpal Roy, Matthew P. Patricelli, Tine Wyseure et al.|Unknown|2026Cited by 0
Supplementary Table 2 from A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer GrowthNilotpal Roy, Matthew P. Patricelli, Tine Wyseure et al.|Unknown|2026Cited by 0